본문 바로가기
KERD
논문KCI 등재

Cognitive Impairment in Parkinson’s Disease without Dementia: Subtypes and Influences of Age

2

조회

0

다운로드

4

인용

0

참고문헌

키워드

초록

Background and Purpose Cognitive impairments are common in Parkinson’s disease (PD), although the severity of these impairments does not significantly impair the patient’s daily activities. The aim of this study was to determine the frequency of mild cognitive impairment (MCI) of Parkinson’s disease (PDMCI) and its subtypes in nondemented PD patients. We also evaluated the influence of age on the pattern of subtypes of PDMCI. Methods A total of 141 consecutive, nondemented PD patients underwent a comprehensive neuropsychological assessment covering the five cognitive domains: attention, language, visuospatial, memory, and executive functions. PDMCI was defined as impaired performance in at least one of these five cognitive domains. The influence of age on the distribution of subtypes of PDMCI was assessed by comparing patients in two groups dichotomized according to their age at assessment (younger vs. older). Results Fifty-seven (40.4%) of the nondemented PD patients had an impairment in at least one domain, and were therefore considered as having PDMCI. The age at assessment and age at disease onset were significantly higher in the PDMCI patients. The amnestic type of PDMCI was the most frequent, followed by the visuospatial, linguistic, executive, and attention types in that order. The frequency of PDMCI was higher for all subtypes in the older group; the domain that was influenced the most by age was executive function. Conclusions MCI was common in PD and the subtypes were diverse. Age was found to be an important risk factor for the development of PDMCI, particularly for the executive subtype. These results indicate that the concept of MCI should be introduced in PD.

Abstract

Background and Purpose Cognitive impairments are common in Parkinson’s disease (PD), although the severity of these impairments does not significantly impair the patient’s daily activities. The aim of this study was to determine the frequency of mild cognitive impairment (MCI) of Parkinson’s disease (PDMCI) and its subtypes in nondemented PD patients. We also evaluated the influence of age on the pattern of subtypes of PDMCI. Methods A total of 141 consecutive, nondemented PD patients underwent a comprehensive neuropsychological assessment covering the five cognitive domains: attention, language, visuospatial, memory, and executive functions. PDMCI was defined as impaired performance in at least one of these five cognitive domains. The influence of age on the distribution of subtypes of PDMCI was assessed by comparing patients in two groups dichotomized according to their age at assessment (younger vs. older). Results Fifty-seven (40.4%) of the nondemented PD patients had an impairment in at least one domain, and were therefore considered as having PDMCI. The age at assessment and age at disease onset were significantly higher in the PDMCI patients. The amnestic type of PDMCI was the most frequent, followed by the visuospatial, linguistic, executive, and attention types in that order. The frequency of PDMCI was higher for all subtypes in the older group; the domain that was influenced the most by age was executive function. Conclusions MCI was common in PD and the subtypes were diverse. Age was found to be an important risk factor for the development of PDMCI, particularly for the executive subtype. These results indicate that the concept of MCI should be introduced in PD.

참고문헌 (22)

  1. Janvin CC, "Subtypes of mild cognitive impairment in Parkinson’s disease: progression to dementia", Mov Disord, 21, pp.1343~1349 (2006)
  2. Caviness JN, "Defining mild cognitive impairment in Parkinson’s disease", Mov Disord, 22, pp.1272~1277 (2007)
  3. Petersen RC, "Current concepts in mild cognitive impairment", Arch Neurol, 58, pp.1985~1992 (2001)
  4. Foltynie T, "The cognitive ability of an incident cohort of Parkinson’s patients in the UK. The Cam- PaIGN study", The Cam- PaIGN study. Brain, 127, pp.550~560 (2004)
  5. Hughes AJ, "A clinicopathologic study of 100 cases of Parkinson’s disease", Arch Neurol, 50, pp.140~148 (1993)
  6. Emre M, "Clinical diagnostic criteria for dementia associated with Parkinson’s disease", Mov Disord, 22, pp.1689~1707 (2007)
  7. Fahn S, "Members of the UPDRS Development Committee. in: Recent development in Parkinson’s disease vol. 2", pp.153~164 (1987), Macmillan Health Care Information
  8. Hoehn MM, "Parkinsonism: onset, progression and mortality", Neurology, 17, pp.427~442 (1967)
  9. Kang Y, "Seoul Neuropsychological Screening Battery" (2003), Human Brain Research & Consulting Co.
  10. Lattin J, "Analyzing Multivariate Data" (2003), Duxbury
  11. Kim H, "Normative data on the Korean version of the Boston Naming Test", J Clin Exp Neuropsychol, 21, pp.127~133 (1999)
  12. Muslimovic D, "Cognitive profile of patients with newly diagnosed Parkinson’s disease", Neurology, 65, pp.1239~1245 (2005)
  13. Green J, "Cognitive impairments in advanced PD without dementia", Neurology, 59, pp.1320~1324 (2002)
  14. Dubois B, "Age-induced cognitive disturbances in Parkinson’s disease", Neurology, 40, pp.38~41 (1990)
  15. Katzen H, "Age of disease onset influences cognition in Parkinson’s disease", J Int Neuropsychol Soc, 4, pp.285~290 (1998)
  16. Aarsland D, "Risk of dementia in Parkinson’s disease: a community-based, prospective study", Neurology, 56, pp.730~736 (2001)
  17. Hughes TA, "A 10-year study of the incidence of and factors predicting dementia in Parkinson’s disease", Neurology, 54, pp.1596~1602 (2000)
  18. Uekermann J, "Depressed mood and executive dysfunction in early Parkinson’s disease", Acta Neurol Scand, 107, pp.341~348 (2003)
  19. Petersen RC, "Mild cognitive impairment: clinical characterization and outcome", Arch Neurol, 56, pp.303~308 (1999)
  20. Boeve BF, "Mild cognitive impairment preceding dementia with Lewy bodies", Neurology, 62(5), pp.A86~A87 (2004)
  21. Petersen RC, "Mild cognitive impairment as a diagnostic entity", J Intern Med, 256, pp.183~194 (2004)
  22. Emre M, "Rivastigmine for dementia associated with Parkinson’s disease", N Engl J Med, 351, pp.2509~2518 (2004)

관련 논문AI추천

Subjective Cognitive Complaints and Objective Cognitive Impairment in Parkinson’s Disease손영호, 이윤주, 이필휴, 홍진용, 선우문경대한신경과학회 · Journal of Clinical Neurology2018 · 제14권 제1호The Association between Motor Laterality and Cognitive Impairment in Parkinson’s Disease김지선, 노학재, 안무영, 이경복, Jae-Young Seo, Jee-Eun Yoon, Jin Whan Cho, Jun-Sang Sunwoo대한치매학회 · Dementia and Neurocognitive Disorders(대한치매학회지)2016 · 제15권 제4호Dementia with Lewy Bodies versus Alzheimer’s Disease and Parkinson’s Disease Dementia: A Comparison of Cognitive Profiles김상호, 김재우, 김현숙, 박경원, 차재관, 천상명대한신경과학회 · Journal of Clinical Neurology2011 · 제7권 제1호Can Silent Ischemic Cerebral Lesions Affect Cognition of Parkinson’s Disease Dementia?강일웅, 김영도, 송인욱, 양영순, 이수진, 정성우, 조현지대한치매학회 · Dementia and Neurocognitive Disorders(대한치매학회지)2013 · 제12권 제3호파킨슨 경도인지장애와 피질하 혈관성 경도인지장애의 인지기능의 비교권오대, 김지혜, 장문선, 진영선, 최소영대한신경과학회 · 대한신경과학회지2011 · 제29권 제3호Gait Patterns in Parkinson's Disease with or without Cognitive Impairment김승민, 양영순, 하상원, Dae Hyun Kim, Jeong Ho Han대한치매학회 · Dementia and Neurocognitive Disorders(대한치매학회지)2018 · 제17권 제2호

이 간행물의 다른 논문 (7건)